BDX

SELL

Becton, Dickinson and Company

Healthcare · Rank #365 · Analyzed Apr 20, 2026

$158.54

Current Price

$1115.66

Intrinsic Value

0.0%

Upside/Downside

1.5/10

Score

1.5/5

Quality

Analysis Summary

Valuation Consensus1/3 methods agree

Quality Score1.5/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 0.0%

Fair Value Range

Low$71.40

Base (IV)$1115.66

High$1559.37

Entry Points

Conservative$71.40

Moderate$593.53

Aggressive$1115.66

⚠️ Warnings

Upside capped: raw 884% exceeds 200% — valuation unreliable

Quality & Moat Breakdown

Return on Equity7.0% → 0/1.0

Debt LevelD/E 77 → 0/1.0

Revenue QualityGrowth 7.8%, margin Δ+0.7% +recovery → 1.0/1.0

Moat Strength1.5/5 → 0/1.0

Profit Margins8.0% → 0.5/1.0

Methodology

This analysis uses a unified valuation framework combining three methods — Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation — with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.